SE432939B - Forfarande for framstellning av nya derivat av beta-1,3-glukan med farmakologisk verkan - Google Patents

Forfarande for framstellning av nya derivat av beta-1,3-glukan med farmakologisk verkan

Info

Publication number
SE432939B
SE432939B SE7713016A SE7713016A SE432939B SE 432939 B SE432939 B SE 432939B SE 7713016 A SE7713016 A SE 7713016A SE 7713016 A SE7713016 A SE 7713016A SE 432939 B SE432939 B SE 432939B
Authority
SE
Sweden
Prior art keywords
glucan
beta
procedure
pharmacological effect
new derivatives
Prior art date
Application number
SE7713016A
Other languages
English (en)
Swedish (sv)
Other versions
SE7713016L (sv
Inventor
T Sasaki
Y Sugino
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE7713016L publication Critical patent/SE7713016L/
Publication of SE432939B publication Critical patent/SE432939B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04—Disaccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE7713016A 1976-11-18 1977-11-17 Forfarande for framstellning av nya derivat av beta-1,3-glukan med farmakologisk verkan SE432939B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13914376A JPS5366442A (en) 1976-11-18 1976-11-18 Antitumors

Publications (2)

Publication Number Publication Date
SE7713016L SE7713016L (sv) 1978-05-19
SE432939B true SE432939B (sv) 1984-04-30

Family

ID=15238550

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7713016A SE432939B (sv) 1976-11-18 1977-11-17 Forfarande for framstellning av nya derivat av beta-1,3-glukan med farmakologisk verkan

Country Status (12)

Country Link
US (1) US4454315A (xx)
JP (1) JPS5366442A (xx)
BE (1) BE860885A (xx)
CA (1) CA1100951A (xx)
CH (1) CH634855A5 (xx)
DE (1) DE2751570A1 (xx)
DK (1) DK510177A (xx)
FR (2) FR2421617A1 (xx)
GB (1) GB1595596A (xx)
NL (1) NL7712764A (xx)
SE (1) SE432939B (xx)
SU (1) SU1024011A3 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404299D0 (en) * 1984-02-18 1984-03-21 Milner Research Ireland Ltd Peritoneal dialysis
US4774093A (en) * 1985-06-25 1988-09-27 Fmc Corporation Polysaccharide compositions, preparation and uses
JPH0653764B2 (ja) * 1985-07-31 1994-07-20 三井東圧化学株式会社 モノシアロガングリオシドの製造法
JPH0692441B2 (ja) * 1986-03-03 1994-11-16 株式会社林原生物化学研究所 β−Ｄ−グルカンとその製造方法及び用途
JPH02124902A (ja) * 1988-07-21 1990-05-14 Takeda Chem Ind Ltd 血液凝固抑制剤
KR0141685B1 (ko) * 1988-09-01 1998-07-01 야마따니 와따루 참게 아메보사이트 라이세이트 g 인자 활성화 저해제
CA1328074C (en) * 1988-09-01 1994-03-29 Shigenori Tanaka Horseshoe crab amebocyte lysate factor g inhibitor
DE3929355A1 (de) * 1989-09-04 1991-03-07 Boehringer Mannheim Gmbh Verfahren zur spezifischen bestimmung von pankreas-(alpha)-amylase
US5227372A (en) * 1990-03-07 1993-07-13 Children's Medical Center Corporation Method for retaining ophthalmological agents in ocular tissues
JP3122454B2 (ja) * 1990-09-27 2001-01-09 生化学工業株式会社 カブトガニ・アメボサイト・ライセートの調製法
CA2081025A1 (en) * 1991-02-21 1992-08-22 Kazuhiro Inoue Carboxymethylmannoglucans and derivatives thereof
US5519009A (en) * 1993-10-01 1996-05-21 Donzis; Byron A. Solubilized yeast glucan
US5760213A (en) * 1995-06-05 1998-06-02 Tayca Corporation Immunoactivating agent
WO1997000687A1 (fr) * 1995-06-22 1997-01-09 Tayca Corporation Immunostimulant
EP1197216B1 (de) * 1996-07-19 2004-06-23 Mibelle AG Cosmetics Pharmazeutische oder kosmetische Zusammensetzung enthaltend polymere Glucanäther-Derivate
CN1272024C (zh) * 1999-07-09 2006-08-30 太阳农场股份有限公司 使用食物添加剂制备治疗恶性肿瘤和病毒感染以及增进免疫功能的药剂的用途
AU2001279796A1 (en) * 2000-08-03 2002-02-18 Abac R & D Gmbh Isolation of glucan particles and uses thereof
US20050026849A1 (en) * 2003-03-28 2005-02-03 Singh Chandra U. Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
US20050022258A1 (en) * 2003-04-25 2005-01-27 Zheng Cui Genetically determined mouse model of resistance to transplantable cancers
CN101184780B (zh) 2005-05-05 2012-10-03 森馨香料公司 β-葡聚糖和甘露聚糖的制备

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3301848A (en) * 1962-10-30 1967-01-31 Pillsbury Co Polysaccharides and methods for production thereof
US3396082A (en) * 1965-06-09 1968-08-06 Agriculture Usa Glucan production by fermentation of fleshy fungi
US3856775A (en) * 1969-07-14 1974-12-24 Ajinomoto Kk {62 -(1{43 3)-glucans
US3754925A (en) * 1970-03-24 1973-08-28 Takeda Chemical Industries Ltd New thermo gelable polysaccharide containing foodstuffs
US3987166A (en) * 1970-05-13 1976-10-19 Kaken Kagaku Kabushiki Kaisha Treatment of tumors with glucan compositions in mice and rats
JPS4837590B1 (xx) * 1970-10-19 1973-11-12

Also Published As

Publication number Publication date
FR2438056A1 (fr) 1980-04-30
SU1024011A3 (ru) 1983-06-15
GB1595596A (en) 1981-08-12
FR2421617A1 (fr) 1979-11-02
CH634855A5 (fr) 1983-02-28
DE2751570A1 (de) 1978-05-24
JPS6152125B2 (xx) 1986-11-12
US4454315A (en) 1984-06-12
FR2421617B1 (xx) 1983-12-23
CA1100951A (en) 1981-05-12
BE860885A (fr) 1978-05-16
FR2438056B1 (xx) 1983-10-21
DK510177A (da) 1978-05-19
NL7712764A (nl) 1978-05-22
JPS5366442A (en) 1978-06-13
SE7713016L (sv) 1978-05-19

Similar Documents

Publication Publication Date Title
SE432939B (sv) Forfarande for framstellning av nya derivat av beta-1,3-glukan med farmakologisk verkan
SE445923B (sv) Forfarande for framstellning av glukosaminderivat
SE7610422L (sv) Forfarande for framstellning av pyrimidinderivat
SE412906B (sv) Forfarande for framstellning av 3-aryloxi-3-fenylpropylaminer med farmakologisk verkan
SE415761B (sv) Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan
SE436202B (sv) Analogiforfarande for framstellning av tetracykliska derivat
SE7605286L (sv) Nya derivat av 4-aminopiperidin
SE7602109L (sv) Nytt forfaringssett for framstellning av nukleosider
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE7704545L (sv) Forfarande for framstellning av nya adeninderivat
SE422065B (sv) Forfarande for framstellning av nya derivat av tiazolo-(3,4-b)-isokinolin
SE7701459L (sv) Forfarande for framstellning av nya derivat av 1,2-ditiol
SE405477B (sv) Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan
NO781704L (no) Fremgangsmaate for fremstilling av sesquiterpenderivater
SE7701379L (sv) Forfarande for framstellning av bensendimetanolderivat med farmakologisk verkan
SE424553B (sv) Forfarande for framstellning av nya indazol-derivat
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
SE7800681L (sv) Forfarande for framstellning av nya derivat av isokinolin
SE7806525L (sv) Nya foreningar med farmakologisk verkan
NO145138C (no) Fremgangsmaate for fremstilling av benz(f)-2,5-oksazociner
SE439159B (sv) Forfarnde for framstellning av nya 5-fluoropyrimidin-4-on-derivat
SE389108B (sv) Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan
SE383874B (sv) Forfarande for framstellning av nya acylaminoderivat av substituerade bisarylalkylaminer med farmakologiska egenskaper
SE424870B (sv) Forfarande for framstellning av etylendiaminplatina (ii)-2,4-dioxopyrimidinkomplex
SE7805588L (sv) Forfarande for framstellning av nya derivat av 4-hydroxitiazolidin-2-tion

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7713016-9

Effective date: 19840808

Format of ref document f/p: F